Werner Skubalia

Title: The Innovative Journey of Werner Skubalia

Introduction

Werner Skubalia is an esteemed inventor based in Berlin, Germany, known for his significant contributions to the field of pharmaceuticals. He holds one patent that showcases his innovative work in microbiology, particularly in the synthesis of prostaglandin intermediates.

Latest Patents

Skubalia's most noteworthy patent is titled "Microbiological reduction of 15-ketoprostaglandin intermediates." This invention outlines a process for preparing a 15.alpha.-hydroxyprostaglandin intermediate characterized by specific chemical formulas that include variations in the phenoxy groups. This patent underscores his expertise and inventive approach in biochemistry and its applications in the medical field.

Career Highlights

Throughout his career, Werner Skubalia has been associated with Schering Aktiengesellschaft, a leading global pharmaceutical company. His time at Schering has allowed him to leverage his skills in microbiological processes, contributing to groundbreaking advancements in drug formulations and therapies.

Collaborations

Skubalia has collaborated with notable colleagues such as Klaus Kieslich and Bernd Raduchel. These partnerships have fostered an environment of innovation, enabling the development of unique solutions in his area of expertise.

Conclusion

In conclusion, Werner Skubalia stands out as a prominent figure in the realm of inventions, particularly within the pharmaceutical industry. His patent not only highlights his innovative capabilities but also reflects the importance of collaboration in achieving scientific advancements. With ongoing contributions to research and development, Skubalia continues to make an impact in his field.